Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Intratumor Regulatory Noncytotoxic NK Cells in Patients with Hepatocellular Carcinoma
Alessandra Zecca, Valeria Barili, Danila Rizzo, et al.
Cells (2021) Vol. 10, Iss. 3, pp. 614-614
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Natural killer cell dysfunction in cancer and new strategies to utilize NK cell potential for cancer immunotherapy
Wanze Zhang, Zhenghua Zhao, Fan Li
Molecular Immunology (2022) Vol. 144, pp. 58-70
Open Access | Times Cited: 37
Hepatitis B virus‐related hepatocellular carcinoma exhibits distinct intratumoral microbiota and immune microenvironment signatures
Yuanjie Liu, Elena S. Kim, Haitao Guo
Journal of Medical Virology (2024) Vol. 96, Iss. 2
Closed Access | Times Cited: 7
Bridging Chronic Inflammation and Digestive Cancer: The Critical Role of Innate Lymphoid Cells in Tumor Microenvironments
Guanliang Shen, Qi Wang, Zhengrui Li, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 12, pp. 4799-4818
Open Access | Times Cited: 7
Advanced Generation Therapeutics: Biomimetic Nanodelivery System for Tumor Immunotherapy
Jie Li, Huamin Zeng, Luwei Li, et al.
ACS Nano (2023) Vol. 17, Iss. 24, pp. 24593-24618
Closed Access | Times Cited: 18
Redefining Hepatocellular Carcinoma Treatment: Nanotechnology Meets Tumor Immune Microenvironment
Chen Mi, Sai Liu, Zhida Chen
Journal of drug targeting (2025), pp. 1-47
Closed Access
Natural Killer Cells and T Cells in Hepatocellular Carcinoma and Viral Hepatitis: Current Status and Perspectives for Future Immunotherapeutic Approaches
Suresh Kalathil, Yasmin Thanavala
Cells (2021) Vol. 10, Iss. 6, pp. 1332-1332
Open Access | Times Cited: 37
Cell-mediated barriers in cancer immunosurveillance
Jafar Rezaie, Leila Chodari, Shadi Mohammadpour-Asl, et al.
Life Sciences (2024) Vol. 342, pp. 122528-122528
Closed Access | Times Cited: 4
Key oncogenic signaling pathways affecting tumor-infiltrating lymphocytes infiltration in hepatocellular carcinoma: basic principles and recent advances
Xiang Wang, Zijun Yuan, Zhengbo Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
The unique role of innate lymphoid cells in cancer and the hepatic microenvironment
Sophie Curio, Gabrielle T. Belz
Cellular and Molecular Immunology (2022) Vol. 19, Iss. 9, pp. 1012-1029
Open Access | Times Cited: 15
Combined targeting of soluble latent TGF-ß and a solid tumor-associated antigen with adapter CAR T cells
Niels Werchau, Bettina Kotter, Elvira Criado-Moronati, et al.
OncoImmunology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 13
NK Cells in a Tug-of-War With Cancer: The Roles of Transcription Factors and Cytoskeleton
E Hui Clarissa Lee, Darren Chen Pei Wong, Jeak Ling Ding
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 16
End-Stage Idiopathic Pulmonary Fibrosis Lung Microenvironment Promotes Impaired NK Activity
Tamara Cruz, Paula A. Agudelo Garcia, Julián A. Chamucero-Millares, et al.
The Journal of Immunology (2023) Vol. 211, Iss. 7, pp. 1073-1081
Closed Access | Times Cited: 6
CITEMO XMBD : A flexible single-cell multimodal omics analysis framework to reveal the heterogeneity of immune cells
Huan Hu, Ruiqi Liu, Chunlin Zhao, et al.
RNA Biology (2022) Vol. 19, Iss. 1, pp. 290-304
Open Access | Times Cited: 10
Approaches to spatially resolving the tumour immune microenvironment of hepatocellular carcinoma
Felix Marsh‐Wakefield, Angela L. Ferguson, Ken Liu, et al.
Therapeutic Advances in Medical Oncology (2022) Vol. 14
Open Access | Times Cited: 10
Immune landscape of hepatocellular carcinoma: From dysregulation of the immune responses to the potential immunotherapies
Atieh Pourbagheri‐Sigaroodi, Majid Momeny, Reza Yazdani, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 5
Closed Access | Times Cited: 1
Phenotypic Characterization by Single-Cell Mass Cytometry of Human Intrahepatic and Peripheral NK Cells in Patients with Hepatocellular Carcinoma
Yuichi Yoshida, Sachiyo Yoshio, Taiji Yamazoe, et al.
Cells (2021) Vol. 10, Iss. 6, pp. 1495-1495
Open Access | Times Cited: 12
Natural Killer Cells and Type 1 Innate Lymphoid Cells in Hepatocellular Carcinoma: Current Knowledge and Future Perspectives
Nicolas Jacquelot, Cyril Seillet, Fernando Souza‐Fonseca‐Guimaraes, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 9044-9044
Open Access | Times Cited: 12
T and NK Cell-Based Immunotherapy in Chronic Viral Hepatitis and Hepatocellular Carcinoma
Paola Fisicaro, Carolina Boni
Cells (2022) Vol. 11, Iss. 2, pp. 180-180
Open Access | Times Cited: 8
Identification of chromatin organization-related gene signature for hepatocellular carcinoma prognosis and predicting immunotherapy response
Jingbo Chen, Xingte Chen, Ting Li, et al.
International Immunopharmacology (2022) Vol. 109, pp. 108866-108866
Closed Access | Times Cited: 8
The Tumor Microenvironment of Hepatocellular Carcinoma: Untying an Intricate Immunological Network
Camilla Volponi, Aurora Gazzillo, Eduardo Bonavita
Cancers (2022) Vol. 14, Iss. 24, pp. 6151-6151
Open Access | Times Cited: 7
Tissue-Resident Innate Immune Cell-Based Therapy: A Cornerstone of Immunotherapy Strategies for Cancer Treatment
Rosalia Busà, Matteo Bulati, Ester Badami, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 6
Poor Prognostic Biomarker KIAA1522 Is Associated with Immune Infiltrates in Hepatocellular Carcinoma
Yongjie Shi, Qiwen Xiao, Sicong Huang, et al.
Journal of Oncology (2023) Vol. 2023, pp. 1-15
Open Access | Times Cited: 3
Therapy-induced modulation of extracellular vesicles in hepatocellular carcinoma
Cherlie Lot Sum Yeung, Judy Wai Ping Yam
Seminars in Cancer Biology (2022) Vol. 86, pp. 1088-1101
Closed Access | Times Cited: 5
Defective Patient NK Function Is Reversed by AJ2 Probiotic Bacteria or Addition of Allogeneic Healthy Monocytes
Meng-Wei Ko, Kawaljit Kaur, Tahmineh Safaei, et al.
Cells (2022) Vol. 11, Iss. 4, pp. 697-697
Open Access | Times Cited: 4
Inhibition of STRA6 suppresses NSCLC growth via blocking STAT3/SREBP-1c axis-mediated lipogenesis
Yue Zhou, Rong Zhou, Ning Wang, et al.
Molecular and Cellular Biochemistry (2024)
Closed Access
Page 1 - Next Page

Scroll to top